Giulio Pasinetti's guest appearances

Giulio Pasinetti

Finding Genius Podcast

Scientific Sense ®

Azra Raza

Eleftherios Mylonakis

Paul Davies

James Shapiro

Paul Turner

Brian Keating

Clair Brown

Robert Lustig

Johns Hopkins

Matthew Johnson

Steven Kotler

Ross Taylor

Scott Smith

Andrew Smith

Dipayan Ghosh

OwlTail

Can Clinical trials show what circumstances trigger the onset of Alzheimer's disease and other forms of Dementia? Research shows that more factors may be at play than previously thought. Listen in to learn:  The percent of clinical trials for Dementia which result in new and valuable discoveries If loneliness can play a role in the onset of Alzheimer's disease How some individuals may be predisposed to Dementia and how this may benefit treatment  Professor of neurology at the Icahn School of Medicine at Mount Sinai, Giulio Pasinetti, shares his vast experience researching Alzheimer's disease and Dementia and what he has learned. Even with the removal of plaque from the brain, patients still seem to suffer Dementia. Outside risk factors like obesity, high blood pressure, diet, and more have all been shown to factor into the onset and severity of Alzheimer's disease. New techniques of targeting and identifying cells in the brain will revolutionize therapeutics treatment conditions. Genetic predisposition can give researched clues into the nature of Dementia, and proactive treatment can significantly benefit the patient if started early enough. For more information, visit https://icahn.mssm.edu/research/molecular-neuroresilience.

Can Clinical trials show what circumstances trigger the onset of Alzheimer's disease and other forms of Dementia? Research shows that more factors may be at play than previously thought. Listen in to learn: <ul> <li>The percent of clinical trials for Dementia which result in new and valuable discoveries</li> <li>If loneliness can play a role in the onset of Alzheimer's disease</li> <li>How some individuals may be predisposed to Dementia and how this may benefit treatment</li> </ul> Professor of neurology at the Icahn School of Medicine at Mount Sinai, Giulio Pasinetti, shares his vast experience researching Alzheimer's disease and Dementia and what he has learned. Even with the removal of plaque from the brain, patients still seem to suffer Dementia. Outside risk factors like obesity, high blood pressure, diet, and more have all been shown to factor into the onset and severity of Alzheimer's disease. New techniques of targeting and identifying cells in the brain will revolutionize therapeutics treatment conditions. Genetic predisposition can give researched clues into the nature of Dementia, and proactive treatment can significantly benefit the patient if started early enough. For more information, visit <a href="https://icahn.mssm.edu/research/molecular-neuroresilience" rel="nofollow" target="_blank">https://icahn.mssm.edu/research/molecular-neuroresilience</a>.

Alzheimer's Disease Therapeutic Research and Revolutionizing Treatment Techniques - A Conversation with Giulio Pasinetti

Effects of food, sleep and the microbiome on Alzheimer’s Disease, Parkinson’s Disease and other neurodegenerative diseases Prof. Giulio Pasinetti is a Professor of Neurology, Neuroscience, and Geriatrics at the Ichan School of Medicine at Mount Sinai (ISMMS). He also serves as the Director of Basic and Biomedical Research in the Center for Geriatric Research and Training at the Bronx Veterans Affairs Medical Center. He is also the Director of the Center for Molecular Integrative Neuroresilience at Mount Sinai.--- Send in a voice message: https://podcasters.spotify.com/pod/show/scientificsense/messageSupport this podcast: https://podcasters.spotify.com/pod/show/scientificsense/support

Effects of food, sleep and the microbiome on Alzheimer’s Disease, Parkinson’s Disease and other neurodegenerative diseases Prof. Giulio Pasinetti is a Professor of Neurology, Neuroscience, and Geriatrics at the Ichan School of Medicine at Mount Sinai (ISMMS). He also serves as the Director of Basic and Biomedical Research in the Center for Geriatric Research and Training at the Bronx Veterans Affairs Medical Center. He is also the Director of the Center for Molecular Integrative Neuroresilience at Mount Sinai.--- Send in a voice message: <a href="https://podcasters.spotify.com/pod/show/scientificsense/message" rel="nofollow" target="_blank">https://podcasters.spotify.com/pod/show/scientificsense/message</a> Support this podcast: <a href="https://podcasters.spotify.com/pod/show/scientificsense/support" rel="payment nofollow" target="_blank">https://podcasters.spotify.com/pod/show/scientificsense/support</a>

Prof. Giulio Pasinetti, Professor of Neurology at the Icahn School of Medicine at Mount Sinai